Understanding how long noncoding RNAs affect phenylketonuria
Molecular Mechanism of long Noncoding RNAs in Phenylketonuria
This study is looking at how certain molecules in our genes, called lncRNAs, might help find new ways to treat phenylketonuria (PKU), a condition caused by changes in a specific gene, and it could lead to better options for people living with PKU.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11015069 on NIH RePORTER |
What this research studies
This research investigates the role of long noncoding RNAs (lncRNAs) in the genetic disorder phenylketonuria (PKU), which is caused by mutations in the phenylalanine hydroxylase (PAH) gene. By studying the interactions between lncRNAs and enzymes, the research aims to uncover new therapeutic strategies for PKU. The team has already shown that specific lncRNAs can influence enzyme activity and reduce harmful levels of phenylalanine in a mouse model. This work could lead to innovative treatments for patients with PKU who currently have limited options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with phenylketonuria, particularly those with specific genetic variants affecting the PAH gene.
Not a fit: Patients with phenylketonuria who do not have the relevant genetic variants or those with other metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively lower phenylalanine levels in PKU patients, improving their health outcomes.
How similar studies have performed: Previous research has shown promise in using lncRNAs for therapeutic purposes in genetic diseases, indicating that this approach may be viable.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Yang, Liuqing — University of Tx Md Anderson Can Ctr
- Study coordinator: Yang, Liuqing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.